MERUS N.V. EO -,09/ NL0011606264 /
2024-06-14 3:29:01 PM | Chg. +1.5000 | Volume | Bid9:45:10 PM | Ask9:58:53 PM | High | Low |
---|---|---|---|---|---|---|
53.0000EUR | +2.91% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 53.0000 | 53.0000 |
GlobeNewswire
06-10
Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...
GlobeNewswire
06-03
Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentati...
GlobeNewswire
06-02
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
05-29
Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
GlobeNewswire
05-28
Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate...
GlobeNewswire
05-23
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
GlobeNewswire
05-23
Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m...
GlobeNewswire
05-08
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
05-06
Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno fo...
GlobeNewswire
04-24
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
GlobeNewswire
04-08
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expre...
GlobeNewswire
04-03
Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire
03-05
Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is...
GlobeNewswire
03-04
Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference
GlobeNewswire
02-28
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire
2023-11-26
Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023
GlobeNewswire
2023-11-02
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GlobeNewswire
2023-10-23
Merus’ Zeno Interim Data Continues to Demonstrate Robust and Durable Responses in NRG1+ Cancer